Aatmaj Healthcare (AATMAJ)₹25.00+5.04%Hospital
In the Mar 2026 quarter (standalone), Aatmaj Healthcare reported sales of ₹13.47 Cr, up 22.5% from Mar 2025, and net profit of ₹0.21 Cr, down 38.2% year on year. For the year to Mar 2026, sales were ₹24.24 Cr and net profit ₹0.72 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 13.69 | 8.54 | 7.14 | 8.48 | 11.00 | 10.77 | 13.47 |
| Expenses | 8.50 | 4.71 | 8.50 | 8.11 | 9.90 | 9.49 | 12.51 |
| Operating Profit | 5.24 | 3.86 | −1.31 | 0.40 | 1.13 | 1.32 | 1.01 |
| OPM % | 38.2% | 45.2% | −18.4% | 4.9% | 10.4% | 12.4% | 7.6% |
| Other Income | 0.00 | 0.23 | 0.60 | 0.75 | 0.55 | 0.43 | 0.51 |
| Interest | 0.66 | 0.60 | 0.67 | 0.38 | 0.52 | 0.58 | 0.81 |
| Depreciation | 0.33 | 0.37 | 0.42 | 0.46 | 0.44 | 0.50 | 0.45 |
| Profit before tax | 4.25 | 3.13 | −1.79 | 0.32 | 0.73 | 0.68 | 0.27 |
| Tax % | 29.3% | 27.3% | −22.3% | 6.0% | 55.4% | 26.0% | 28.5% |
| Net Profit | 3.02 | 2.30 | −1.42 | 0.32 | 0.34 | 0.52 | 0.21 |
| EPS (Rs) | 1.87 | 1.02 | −0.63 | 0.15 | 0.16 | 0.24 | 0.10 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 4.12 | 15.44 | 20.18 | 23.65 | 14.78 | 19.11 | 24.24 |
| Expenses | 3.47 | 10.22 | 12.76 | 13.92 | 12.30 | 17.63 | 21.99 |
| Operating Profit | 0.66 | 5.28 | 7.49 | 9.81 | 2.54 | 1.54 | 2.35 |
| OPM % | 16.3% | 34.2% | 37.2% | 41.4% | 17.2% | 8.1% | 9.8% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.02 | 0.84 | 1.31 | 0.95 |
| Interest | 0.51 | 0.45 | 0.25 | 0.91 | 1.26 | 0.89 | 1.39 |
| Depreciation | 0.35 | 0.38 | 0.42 | 0.68 | 0.80 | 0.91 | 0.96 |
| Profit before tax | −0.17 | 4.45 | 6.83 | 8.26 | 1.33 | 1.06 | 0.96 |
| Tax % | 49.9% | 7.4% | 26.0% | 28.6% | 34.3% | 40.2% | 26.8% |
| Net Profit | −0.28 | 4.13 | 5.07 | 5.93 | 0.89 | 0.65 | 0.72 |
| EPS (Rs) | −2.01 | 30.61 | 37.53 | 3.66 | 0.40 | 0.29 | 0.32 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 12.8% | 0.0% | 0.0% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 1.35 | 1.35 | 1.35 | 8.08 | 11.29 | 11.31 | 11.29 |
| Reserves | −2.28 | 1.83 | 6.90 | 6.05 | 38.03 | 38.68 | 39.36 |
| Borrowings | 8.74 | 4.32 | 5.18 | 11.67 | 5.47 | 10.06 | 21.01 |
| Other Liabilities | 1.48 | 2.27 | 4.01 | 5.12 | 2.71 | 3.05 | 4.76 |
| Total Liabilities | 9.29 | 9.77 | 17.44 | 30.92 | 57.50 | 63.10 | 76.42 |
| Fixed Assets | 7.99 | 8.19 | 10.85 | 11.14 | 18.13 | 17.96 | 29.39 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.52 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 1.30 | 1.58 | 6.59 | 19.78 | 39.37 | 45.14 | 46.51 |
| Inventories | 0.13 | 0.20 | 0.40 | 0.39 | 0.63 | 0.70 | 1.58 |
| Trade receivables | 0.99 | 0.58 | 5.11 | 17.85 | 20.64 | 24.62 | 24.57 |
| Cash & equivalents | 0.03 | 0.54 | 0.19 | 0.31 | 10.80 | 12.15 | 11.69 |
| Total Assets | 9.29 | 9.77 | 17.44 | 30.92 | 57.50 | 63.10 | 76.42 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | −0.55 | 6.12 | 9.57 | 5.34 | −8.03 | 3.35 | 7.09 |
| Cash from investing activity | −0.19 | −0.72 | −3.38 | −1.43 | −7.85 | −0.70 | −12.42 |
| Cash from financing activity | 0.68 | −4.86 | −6.54 | −3.77 | 26.30 | −1.28 | 4.84 |
| Net cash flow | −0.04 | 0.52 | −0.36 | 0.13 | 10.48 | 1.34 | −0.46 |
| Capex | 0.19 | 0.58 | 3.11 | 0.99 | 7.83 | 0.75 | 12.56 |
| Free cash flow | −0.73 | 5.53 | 6.46 | 4.34 | −15.82 | 2.59 | −5.33 |
| CFO / OP % | −81.0% | 120.0% | 104.0% | 32.0% | −327.0% | 192.0% | 290.0% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 87 | 13 | 92 | 274 | 507 | 468 | 368 |
| Inventory days | 64 | 17 | — | — | — | — | 220 |
| Days payable | 493 | 148 | — | — | — | — | 245 |
| Cash conversion cycle | −343 | −117 | 92 | 274 | 507 | 468 | 343 |
| Working capital days | −166 | −46 | −28 | 79 | 555 | 427 | 283 |
| ROCE % | — | 63.8% | 67.5% | 46.6% | 6.4% | 3.4% | 3.6% |
For the Mar 2026 quarter, Aatmaj Healthcare reported sales of ₹13.47 Cr, up 22.5% year on year and net profit of ₹0.21 Cr, down 38.2% year on year. The operating margin was 7.6%.
Aatmaj Healthcare's sales for the year to Mar 2026 were ₹24.24 Cr.
Net profit for the year to Mar 2026 was ₹0.72 Cr. Earnings per share over the same trailing period were ₹0.32.
Aatmaj Healthcare reported borrowings of ₹21.01 Cr at Mar 2026, against cash and equivalents of ₹11.69 Cr.
Cash from operations was ₹7.09 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹5.33 Cr.